Roundview Capital LLC - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 60 filers reported holding CASI PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Roundview Capital LLC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$31,000
-68.4%
38,112
-68.9%
0.00%
-70.0%
Q4 2021$98,000
-32.9%
122,4530.0%0.01%
-37.5%
Q3 2021$146,000
-23.2%
122,4530.0%0.02%
-23.8%
Q2 2021$190,000
-44.9%
122,453
-14.8%
0.02%
-51.2%
Q1 2021$345,000143,6770.04%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders